These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34939553)

  • 1. Non-hepatic Hyperammonemia: A Potential Therapeutic Target for Sepsis-associated Encephalopathy.
    Zhao L; Li Y; Wang Y; Ge Z; Zhu H; Zhou X; Li Y
    CNS Neurol Disord Drug Targets; 2022; 21(9):738-751. PubMed ID: 34939553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of serum ammonia in patients with sepsis-associated encephalopathy without hepatic failure.
    Zhao L; Hou S; Na R; Liu B; Wang Z; Li Y; Xie K
    Front Public Health; 2022; 10():1016931. PubMed ID: 36684934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of Patients with Sepsis and Non-Hepatic Hyperammonemia: A Cohort Study.
    Zhao L; Gao Y; Guo S; Lu X; Yu S; Ge Z; Zhu H; Li Y
    Med Sci Monit; 2020 Dec; 26():e928573. PubMed ID: 33373333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Sepsis and Sepsis-Associated Encephalopathy.
    Feng Q; Ai YH; Gong H; Wu L; Ai ML; Deng SY; Huang L; Peng QY; Zhang LN
    J Intensive Care Med; 2019; 34(11-12):938-945. PubMed ID: 28718340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament light chains to assess sepsis-associated encephalopathy: Are we on the track toward clinical implementation?
    Bircak-Kuchtova B; Chung HY; Wickel J; Ehler J; Geis C
    Crit Care; 2023 May; 27(1):214. PubMed ID: 37259091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Nonhepatic Serum Ammonia Levels and Sepsis-Associated Encephalopathy: A Retrospective Cohort Study.
    Wang P; Yan J; Shi Q; Yang F; Li X; Shen Y; Liu H; Xie K; Zhao L
    Emerg Med Int; 2023; 2023():6676033. PubMed ID: 37869361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Neuroprotective Agents for Sepsis-Associated Encephalopathy: A Comprehensive Review.
    Krzyzaniak K; Krion R; Szymczyk A; Stepniewska E; Sieminski M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for hyperammonemia.
    Hadjihambi A; Khetan V; Jalan R
    Expert Opin Pharmacother; 2014 Aug; 15(12):1685-95. PubMed ID: 25032885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of sepsis-associated encephalopathy risk factors in elderly patients: a retrospective observational cohort study.
    Jin G; Wang S; Chen J; Hu W; Zhu Y; Xi S
    Turk J Med Sci; 2022 Oct; 52(5):1513-1522. PubMed ID: 36422495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central role of microglia in sepsis-associated encephalopathy: From mechanism to therapy.
    Yan X; Yang K; Xiao Q; Hou R; Pan X; Zhu X
    Front Immunol; 2022; 13():929316. PubMed ID: 35958583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of sepsis-associated encephalopathy: epidemiology, clinical features and adverse outcomes.
    Chen J; Shi X; Diao M; Jin G; Zhu Y; Hu W; Xi S
    BMC Emerg Med; 2020 Oct; 20(1):77. PubMed ID: 33023479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's new on septic encephalopathy? Ten things you need to know.
    Ferlini L; Gaspard N
    Minerva Anestesiol; 2023 Mar; 89(3):217-225. PubMed ID: 35833857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy.
    DeWulf B; Minsart L; Verdonk F; Kruys V; Piagnerelli M; Maze M; Saxena S
    Cells; 2023 Apr; 12(7):. PubMed ID: 37048161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Lactulose: Treatment Options for Hepatic Encephalopathy.
    Said VJ; Garcia-Trujillo E
    Gastroenterol Nurs; 2019; 42(3):277-285. PubMed ID: 31145253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PERK-STING-RIPK3 pathway facilitates cognitive impairment by inducing neuronal necroptosis in sepsis-associated encephalopathy.
    Xiaofeng G; You W; Qi J; Hongwei M; Zhongmin F; Shiquan W; Lixia D; Yuliang P; Zongping F; Xijing Z
    CNS Neurosci Ther; 2023 Apr; 29(4):1178-1191. PubMed ID: 36694328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting novel regulated cell death：Ferroptosis, pyroptosis, and autophagy in sepsis-associated encephalopathy.
    Sun J; Fleishman JS; Liu X; Wang H; Huo L
    Biomed Pharmacother; 2024 May; 174():116453. PubMed ID: 38513593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis and the brain: a review for acute and general physicians.
    Carter BL; Underwood J
    Clin Med (Lond); 2022 Sep; 22(5):392-395. PubMed ID: 36507825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NHH promotes Sepsis-associated Encephalopathy with the expression of AQP4 in astrocytes through the gut-brain Axis.
    Zhao L; Zhang Z; Wang P; Zhang N; Shen H; Wu H; Wei Z; Yang F; Wang Y; Yu Z; Li H; Hu Z; Zhai H; Wang Z; Su F; Xie K; Li Y
    J Neuroinflammation; 2024 May; 21(1):138. PubMed ID: 38802927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepsis-associated encephalopathy and septic encephalitis: an update.
    Tauber SC; Djukic M; Gossner J; Eiffert H; Brück W; Nau R
    Expert Rev Anti Infect Ther; 2021 Feb; 19(2):215-231. PubMed ID: 32808580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Biomarkers of Sepsis-Associated Encephalopathy (SAE): Metabolomics Evidence from Gas Chromatography-Mass Spectrometry.
    Zhu J; Zhang M; Han T; Wu H; Xiao Z; Lin S; Wang C; Xu F
    Biomed Res Int; 2019; 2019():2612849. PubMed ID: 31781604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.